Hyperoxia preconditioning: The next frontier in neurology?

Neurological Research

Volumn 34, Issue 5, 2012, Pages 415-421

  Liu, Wenwu ^a   Liu, Kan ^a   Tao, Hengyi ^a   Chen, Chunhua ^b   Zhang, John H ^c   Sun, Xuejun ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antioxidation; Apoptosis; Autophagy; Hyperoxia preconditioning; Hypoxia inducible factor

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; OXYGEN; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; AUTOPHAGY; BRAIN OXYGEN CONSUMPTION; BRAIN OXYGEN TENSION; CLINICAL EFFECTIVENESS; HUMAN; HYPERBARIC OXYGEN; HYPEROXIA; HYPEROXIA PRECONDITIONING; MOLECULAR MECHANICS; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; HUMANS; HYPEROXIA; ISCHEMIC PRECONDITIONING; NEUROLOGY; REACTIVE OXYGEN SPECIES;

EID: 84863804713     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132812Y.0000000034     Document Type: Review

References (88)

1. Bitterman H. Bench-to-bedside review: oxygen as a drug. Crit Care. 2009;13:205.
2. Thom SR. Hyperbaric oxygen: its mechanisms and efficacy. Plast Reconstr Surg. 2011;127:131S-41S.
3. Liu W, Khatibi N, Sridharan A, Zhang JH. Application of medical gases in the field of neurobiology. Med Gas Res. 2011;1:13.
4. http://www.iwh.on.ca/primary-secondary-and-tertiary-prevention
5. Venugopal V, Hausenloy DJ, Ludman A, Di Salvo C, Kolvekar S, Yap J, et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trial. Heart. 2009;95:1567-71.
6. Sano T, Izuishi K, Hossain MA, Kakinoki K, Okano K, Masaki T, et al. Protective effect of lipopolysaccharide preconditioning in hepatic ischaemia reperfusion injury. HPB (Oxford). 2010;12:538-45.
7. Du F, Zhu L, Qian ZM, Wu XM, Yung WH, Ke Y. Hyperthermic preconditioning protects astrocytes from ischemia/reperfusion injury by up-regulation of HIF-1 alpha expression and binding activity. Biochim Biophys Acta. 2010;1802:1048-53.
8. Saghyan A, LaTorre GN, Keesey R, Sharma A, Mehta V, Rudenko V, et al. Glutamatergic and morphological alterations associated with early life seizure-induced preconditioning in young rats. Eur J Neurosci. 2010;32:1897-911.
9. Grimm C, Hermann DM, Bogdanova A, Hotop S, Kilic U, Wenzel A, et al. Neuroprotection by hypoxic preconditioning: HIF-1 and erythropoietin protect from retinal degeneration. Semin Cell Dev Biol. 2005;16:531-8.
10. Bigdeli MR, Hajizadeh S, Froozandeh M, Rasulian B, Heidarianpour A, Khoshbaten A. Prolonged and intermittent normobaric hyperoxia induce different degrees of ischemic tolerance in rat brain tissue. Brain Res. 2007;1152:228-33.
11. Yogaratnam JZ, Laden G, Guvendik L, Cowen M, Cale A, Griffin S. Hyperbaric oxygen preconditioning improves myocardial function, reduces length of intensive care stay, and limits complications post coronary artery bypass graft surgery. Cardiovasc Revasc Med. 2010;11:8-19.
12. Dahl NA, Balfour WM. Prolonged anoxic survival due to anoxia pre-exposure: brain ATP, lactate, and pyruvate. Am J Physiol. 1964;207:452-6.
13. Schurr A, Reid KH, Tseng MT West C, Rigor BM. Adaptation of adult brain tissue to anoxia and hypoxia in vitro. Brain Res. 1986;374:244-8.
14. Geft IL, Fishbein MC, Ninomiya K, Hashida J, Chaux E, Yano J, et al. Intermittent brief periods of ischemia have a cumulative effect and may cause myocardial necrosis. Circulation. 1982;66:1150-3.
15. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-36.
16. Kitagawa K, Matsumoto M, Kuwabara K, Tagaya M, Ohtsuki T, Hata R, et al. 'Ischemic tolerance' phenomenon detected in various brain regions. Brain Res. 1991;561:203-11.
17. Chevion M, Leibowitz S, Aye NN, Novogrodsky O, Singer A, Avizemer O, et al. Heart protection by ischemic preconditioning: a novel pathway initiated by iron and mediated by ferritin. J Mol Cell Cardiol. 2008;45:839-45.
18. Rehni AK, Singh TG, Behl N, Arora S. Possible involvement of ubiquitin proteasome system and other proteases in acute and delayed aspects of ischemic preconditioning of brain in mice. Biol Pharm Bull. 2010;33:1953-7.
19. Xia ZY, Gao J, Ancharaz AK. Protective effect of ischemic postconditioning on lung ischemia-reperfusion injury in rats and the role of heme oxygenase-1. Chin J Traumatol. 2009;12:162-6.
20. Cho WY, Choi HM, Lee SY, Kim MG, Kim HK, Jo SK. The role of Tregs and CD11c(z) macrophages/dendritic cells ischemic preconditioning of the kidney. Kidney Int. 2010;78:981-92.
21. Romanque P, Díaz A, Tapia G, Uribe-Echevarría S, Videla LA, Fernandez V. Delayed ischemic preconditioning protects against liver ischemia-reperfusion injury in vivo. Transplant Proc. 2010;42:1569-75.
22. Baharvand B, Dehaj ME, Foadaddini M, Uribe-Echevarría S, Videla LA, Fernandez V. Delayed cardioprotective effects of hyperoxia preconditioning prolonged by intermittent exposure. J Surg Res. 2010;160:53-9.
23. Rahman IA, Mascaro JG, Steeds RP, Frenneaux MP, Nightingale P, Gosling P, et al. Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment? Circulation. 2010;122:S53-9.
24. Martin WJ. 2nd, Howard DM. Paraquat-induced neutrophil alveolitis: reduction of the inflammatory response by pretreatment with endotoxin and hyperoxia. Lung. 1986;164:107-20.
25. D'Brot J, Ahmed T. Hyperoxia prevents hypoxia-induced bronchial hyperreactivity via a cyclooxygenase-independent mechanism. J Appl Physiol. 1991;70:740-7.
26. Wada K, Ito M, Miyazawa T, Katoh H, Nawashiro H, Shima K, et al. Repeated hyperbaric oxygen induces ischemic tolerance in gerbil hippocampus. Brain Res. 1996;740:15-20.
27. Ostrowski RP, Jadhav V, Chen W, Zhang JH. Reduced matrix metalloproteinase-9 activity and cell death after global ischemia in the brain preconditioned with hyperbaric oxygen. Acta Neurochir Suppl. 2010;106:47-9.
28. Yamashita S, Hirata T, Mizukami Y, Cui YJ, Fukuda S, Ishida K, et al. Repeated preconditioning with hyperbaric oxygen induces neuroprotection against forebrain ischemia via suppression of p38 mitogen activated protein kinase. Brain Res. 2009;1301:171-9.
29. Jadhav V, Ostrowski RP, Tong W, Matus B, Jesunathadas R, Zhang JH. Cyclo-oxygenase-2 mediates hyperbaric oxygen preconditioning-induced neuroprotection in the mouse model of surgical brain injury. Stroke 2009;40:3139-42.
30. Li JS, Zhang W, Kang ZM, Ding SJ, Liu WW, Zhang JH, et al. Hyperbaric oxygen preconditioning reduces ischemia-reperfusion injury by inhibition of apoptosis via mitochondrial pathway in rat brain. Neuroscience. 2009;159:1309-15.
31. Li Z, Liu W, Kang Z, Lv S, Han C, Yun L, et al. Mechanism of hyperbaric oxygen preconditioning in neonatal hypoxia-ischemia rat model. Brain Res. 2008;1196:151-6.
32. Qin Z, Hua Y, Liu W, Silbergleit R, He Y, Keep RF, et al. Hyperbaric oxygen preconditioning activates ribosomal protein S6 kinases and reduces brain swelling after intracerebral hemorrhage. Acta Neurochir Suppl. 2008;102:317-20.
33. Wang L, Li W, Kang Z, Liu Y, Deng X, Tao H, et al. Hyperbaric oxygen preconditioning attenuates early apoptosis after spinal cord ischemia in rats. J Neurotrauma. 2009;26:55-66.
34. Borges JC, Ramos CH. Protein folding assisted by chaperones. Protein Pept Lett. 2005;12:257-61.
35. Brown IR. Heat shock proteins and protection of the nervous system. Ann N Y Acad Sci. 2007;1113:147-58.
36. Vince RV, Midgley AW, Laden G, Madden LA. The effect of hyperbaric oxygen preconditioning on heat shock protein 72 expression following in vitro stress in human monocytes. Cell Stress Chaperones. 2011;16:339-43.
37. Zhang X, Xiong L, Hu W, Zheng Y, Zhu Z, Liu Y, et al. Preconditioning with prolonged oxygen exposure induces ischemic tolerance in the brain via oxygen free radical formation. Can J Anaesth. 2004;51:258-63.
38. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44-84.
39. Li J, Liu W, Ding S, Xu W, Guan Y, Zhang JH, et al. Hyperbaric oxygen preconditioning induces tolerance against brain ischemia-reperfusion injury by upregulation of antioxidant enzymes in rats. Brain Res. 2008;1210:223-9.
40. Nie H, Xiong L, Lao N, Chen S, Xu N, Zhu Z. Hyperbaric oxygen preconditioning induces tolerance against spinal cord ischemia by upregulation of antioxidant enzymes in rabbits. J Cereb Blood Flow Metab. 2006;26:666-74.
41. Bigdeli MR. Preconditioning with prolonged normobaric hyperoxia induces ischemic tolerance partly by upregulation of antioxidant enzymes in rat brain tissue. Brain Res. 2009;1260:47-54.
42. Bigdeli MR, Rasoulian B, Meratan AA. In vivo normobaric hyperoxia preconditioning induces different degrees of antioxidant enzymes activities in rat brain tissue. Eur J Pharmacol. 2009;611:22-9.
43. Turkseven S, Kruger A, Mingone CJ, Kaminski P, Inaba M, Rodella LF, et al. Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am J Physiol Heart Circ Physiol. 2005;289:H701-7.
44. Stocker R, McDonagh AF, Glazer AN, Ames BN. Antioxidant activities of bile pigments: biliverdin and bilirubin. Methods Enzymol. 1990;186:301-9.
45. Leffler CW, Parfenova H, Jaggar JH. Carbon monoxide as an endogenous vascular modulator. Am J Physiol Heart Circ Physiol. 2011;301:H1-11.
46. Peng Z, Ren P, Kang Z, Du J, Lian Q, Liu Y, et al. Upregulated HIF-1alpha is involved in the hypoxic tolerance induced by hyperbaric oxygen preconditioning. Brain Res. 2008;1212:71-8.
47. Gu GJ, Li YP, Peng ZY, Xu JJ, Kang ZM, Xu WG, et al. Mechanism of ischemic tolerance induced by hyperbaric oxygen preconditioning involves upregulation of hypoxia-inducible factor-1a and erythropoietin in rats. J Appl Physiol. 2008;104:1185-91.
48. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999;399:271-5.
49. Correia SC, Santos RX, Perry G. Prolyl hydroxylase domain inhibitors: a route to HIF activation and neuroprotection. J Alzheimers Dis. 2010;20:S475-85.
50. Ren P, Kang Z, Gu G, Liu Y, Xu W, Tao H, et al. Hyperbaric oxygen preconditioning promotes angiogenesis in rat liver after partial hepatectomy. Life Sci. 2008;83:236-41.
51. Jadhav V, Ostrowski RP, Tong W, Matus B, Jesunathadas R, Zhang JH. Cyclo-oxygenase-2 mediates hyperbaric oxygen preconditioning-induced neuroprotection in the mouse model of surgical brain injury. Stroke. 2009;40:3139-42.
52. Cheng O, Ostrowski RP, Wu B, Liu W, Chen C, Zhang JH. Cyclooxygenase-2 mediates hyperbaric oxygen preconditioning in the rat model of transient global cerebral ischemia. Stroke. 2011;42:484-90.
53. Liu W, Li J, Sun X, Liu K, Zhang JH, Xu W, et al. Repetitive hyperbaric oxygen exposures enhance sensitivity to convulsion by upregulation of eNOS and nNOS. Brain Res. 2008;1201:128-34.
54. Kietzmann T, Knabe W, Schmidt-Kastner R. Hypoxia and hypoxia-inducible factor modulated gene expression in brain: involvement in neuroprotection and cell death. Eur Arch Psychiatry Clin Neurosci. 2001;251:170-8.
55. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest. 2003;111:1843-51.
56. Dang S, Liu X, Fu P, Gong W, Yan F, Han P, et al. Neuroprotection by local intra-arterial infusion of erythropoietin after focal cerebral ischemia in rats. Neurol Res. 2011;33:520-8.
57. Ostrowski RP, Graupner G, Titova E, Zhang J, Chiu J, Dach N, et al. The hyperbaric oxygen preconditioning-induced brain protection is mediated by a reduction of early apoptosis after transient global cerebral ischemia. Neurobiol Dis. 2008;29:1-13.
58. Ruusalepp A, Czibik G, Flatebø T, Vaage J, Valen G. Myocardial protection evoked by hyperoxic exposure involves signaling through nitric oxide and mitogen activated protein kinases. Basic Res Cardiol. 2007;102:318-26.
59. Nakamura K, Martin KC, Jackson JK, Beppu K, Woo CW, Thiele CJ. Brain derived neurotrophic factor activation of Trk B induces vascular endothelial growth factor expression via hypoxia inducible factor-1a in neuroblastoma cells. Cancer Res. 2006;66:4249-55.
60. Hee HB, Choi J, Holtzman DM. Evidence that p38 mitogenactivated protein kinase contributes to neonatal hypoxicischemic brain injury. Dev Neurosci. 2002;24:405-10.
61. Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med. 2009;15:331-7.
62. Chen WQ, Ostrowski RP, Obenaus A, Zhang JH. Prodeath or prosurvival: two facets of hypoxia inducible factor-1 in perinatal brain injury. Exp Neurol. 2009;216:7-15.
63. Svedin P, Hagberg H, Sävman K, Zhu C, Mallard C. Matrix metalloproteinase-9 gene knock-out protects the immature brain after cerebral hypoxia-ischemia. J Neurosci. 2007;27:1511-8.
64. Fathali N, Ostrowski RP, Lekic T, Jadhav V, Tong W, Tang J, et al. Cyclooxygenase-2 inhibition provides lasting protection against neonatal hypoxic-ischemic brain injury. Crit Care Med. 2010;38:572-8.
65. Peeters-Scholte C, Koster J, Veldhuis W, van den Tweel E, Zhu C, et al. Neuroprotection by selective nitric oxide synthase inhibition at 24 hours after perinatal hypoxia-ischemia. Stroke. 2002;33:2304-10.
66. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239-57.
67. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456-62.
68. Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA. Mitochondria: the missing link between preconditioning and neuroprotection. J Alzheimers Dis. 2010;20:S475-85.
69. Petrosillo G, Di Venosa N, Moro N, Colantuono G, Paradies V, Tiravanti E, et al. In vivo hyperoxic preconditioning protects against rat-heart ischemia/reperfusion injury by inhibiting mitochondrial permeability transition pore opening and cytochrome c release. Free Radic Biol Med. 2011;50:477-83.
70. Kundu M, Thompson CB. Autophagy: basic principles and relevance to disease. Annu Rev Pathol. 2008;3:427-55.
71. Shacka JJ, Roth KA, Zhang J. The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy. Front Biosci. 2008;13:718-36.
72. Sheng R, Zhang LS, Han R, Liu XQ, Gao B, Qin ZH. Autophagy activation is associated with neuroprotection in a rat model of focal cerebral ischemic preconditioning. Autophagy. 2010;6.
73. Wang YC, Zhang S, Du TY, Wang B, Sun XQ. Hyperbaric oxygen preconditioning reduces ischemia-reperfusion injury by stimulating autophagy in neurocyte. Brain Res. 2010;1323:149-51.
74. Yan W, Zhang H, Bai X, Lu Y, Dong H, Xiong L. Autophagy activation is involved in neuroprotection induced by hyperbaric oxygen preconditioning against focal cerebral ischemia in rats. Brain Res. 2011;1402:109-21.
75. Puyal J, Clarke PG. Targeting autophagy to prevent neonatal stroke damage. Autophagy. 2009;5:1060-1.
76. Chao XD, Fei F, Fei Z. The role of excitatory amino acid transporters in cerebral ischemia. Neurochem Res. 2010;35:1224-30.
77. Tilleux S, Goursaud S, Hermans E. Selective up-regulation of GLT-1 in cultured astrocytes exposed to soluble mediators released by activated microglia. J Neurochem Int. 2009;55:35-40.
78. Bigdeli MR, RahnemaM, Khoshbaten A. Preconditioning with sublethal ischemia or intermittent normobaric hyperoxia upregulates glutamate transporters and tumor necrosis factoralpha converting enzyme in the rat brain. J Stroke Cerebrovasc Dis. 2009;18:336-42.
79. Colantuono G, Tiravanti EA, Di Venosa N, Cazzato A, Rastaldo R, Cagiano R, et al. Hyperoxia confers myocardial protection in mechanically ventilated rats through the generation of free radicals and opening of mitochondrial ATPsensitive potassium channels. Clin Exp Pharmacol Physiol. 2008;35:64-71.
80. Labruto F, Yang J, Vaage J, Valen G. Role of tumor necrosis factor alpha and its receptor I in preconditioning by hyperoxia. Basic Res Cardiol. 2005;100:198-207.
81. Tähepõld P, Vaage J, Starkopf J, Valen G. Hyperoxia elicits myocardial protection through a nuclear factor kappaBdependent mechanism in the rat heart. J Thorac Cardiovasc Surg. 2003;125:650-60.
82. Berven LA, Crouch MF. Cellular function of p70S6K: a role in regulating cell motility. Immunol Cell Biol. 2000;78:447-51.
83. Hirata T, Cui YJ, Funakoshi T, Mizukami Y, Ishikawa Y, Shibasaki F, et al. The temporal profile of genomic responses and protein synthesis in ischemic tolerance of the rat brain induced by repeated hyperbaric oxygen. Brain Res. 2007;1130:214-22.
84. Rockswold SB, Rockswold GL, Zaun DA, Zhang X, Cerra CE, Bergman TA, et al. A prospective, randomized clinical trial to compare the effect of hyperbaric to normobaric hyperoxia on cerebral metabolism, intracranial pressure, and oxygen toxicity in severe traumatic brain injury. J Neurosurg. 2010;112:1080-94.
85. Kaljusto ML, Stensløkken KO, Mori T, Panchenko A, Frantzen ML, Valen G, et al. Preconditioning effects of steroids and hyperoxia on cardiac ischemia-reperfusion injury and vascular reactivity. Eur J Cardiothorac Surg. 2008;33:355-63.
86. Li Y, Dong H, Chen M, Liu J, Yang L, Chen S, et al. Preconditioning with repeated hyperbaric oxygen induces myocardial and cerebral protection in patients undergoing coronary artery bypass graft surgery: A prospective, randomized, controlled clinical trial. J Cardiothorac Vasc Anesth. 2011;25:908-16.
87. Thom SR, Bhopale VM, Velazquez OC, Goldstein LJ, Thom LH, Buerk DG. Stem cell mobilization by hyperbaric oxygen. Am J Physiol Heart Circ Physiol. 2006;290:H1378-86.
88. Rueger MA, Backes H, Walberer M, Neumaier B, Ullrich R, Simard ML, et al. Noninvasive imaging of endogenous neural stem cell mobilization in vivo using positron emission tomography. J Neurosci. 2010;30:6454-60.